Newsroom | 5661 results

SOUTH BURLINGTON, Vt. & SALT LAKE CITY--(BUSINESS WIRE)--BETA Technologies, Inc. (NYSE: BETA) (BETA), an aerospace and defense company, today concluded five days of flight operations in Utah that demonstrated how electric aviation can provide reliable, time-sensitive movement of critical medical cargo across the state under the U.S. Department of Transportation’s (U.S. DOT) and Federal Aviation Administration’s (FAA) eVTOL Integration Pilot Program (eIPP). “Cargo, logistics and medical missions...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also wil...

SALT LAKE CITY--(BUSINESS WIRE)--Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, today announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing lab-in-the loop drug discovery. The effort brings together scientific and technical expertise to connect laboratory systems, software and data infrastructure with AI-driven discovery workflows. Lab-in-the-loop – t...

CLAYMONT, Del.--(BUSINESS WIRE)--MRI2CT received FDA 510(k) clearance for NextMR, enabling 3D bone visualization from standard spine MRI....

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia, Inc., een toonaangevend bedrijf op het gebied van precisie-oncologie voor borstkanker, heeft vandaag aangekondigd dat het tijdens het congres van de European Society for Medical Oncology (ESMO) in 2026, dat plaatsvindt van 23 t/m 27 oktober 2026 in Madrid, nieuw onderzoek zal presenteren. Dit onderzoek betreft de ontwikkeling van een op kunstmatige intelligentie (AI) gebaseerde methode voor digitale pathologie ten behoeve van MammaPrintⓇ. Da...

IRVINE, California y ÁMSTERDAM--(BUSINESS WIRE)--Agendia, Inc., empresa líder en oncología de precisión para el cáncer de mama, anunció hoy que presentará nuevas investigaciones en una sesión oral sobre el desarrollo de un nuevo enfoque de patología digital con inteligencia artificial para MammaPrintⓇ en el Congreso de la Sociedad Europea de Oncología Médica (ESMO) 2026, que se celebrará del 23 al 27 de octubre de 2026 en Madrid. La compañía también presentará dos pósteres adicionales en el mar...

IRVINE, Kalifornien & AMSTERDAM--(BUSINESS WIRE)--Agendia, Inc., ein führendes Unternehmen im Bereich der Präzisionsonkologie bei Brustkrebs, gab heute bekannt, dass es bei der Tagung der European Society for Medical Oncology (ESMO) vom 23. bis zum 27. Oktober 2026 in Madrid im Rahmen einer Podiumspräsentation zur Entwicklung einer KI-gestützten Methode der digitalen Pathologie für MammaPrintⓇ neue Untersuchungen präsentieren wird. Das Unternehmen wird bei der ESMO zudem zwei zusätzliche Poster...

IRVINE, California e AMSTERDAM--(BUSINESS WIRE)--Agendia, Inc., un’azienda leader nel settore dell’oncologia di precisione per il tumore al seno, oggi ha annunciato che presenterà i risultati di una nuova ricerca sullo sviluppo di un approccio di patologia digitale basato sull’intelligenza artificiale (IA) a MammaPrintⓇ al Congresso della European Society for Medical Oncology (ESMO) 2026, che si terrà dal 23 al 27 ottobre 2026 a Madrid. Agendia presenterà inoltre due ulteriori poster in occasio...

IRVINE, Californie et AMSTERDAM--(BUSINESS WIRE)--Agendia, Inc., un leader de l'oncologie de précision pour le cancer du sein, annonce aujourd'hui qu'il présentera de nouvelles recherches lors d'une présentation sur le développement d'une approche de pathologie numérique axée sur l'intelligence artificielle (IA) pour MammaPrintⓇ lors du Congrès 2026 de la Société européenne d'oncologie médicale (ESMO), qui se tiendra du 23 au 27 octobre 2026 à Madrid. La société présentera également deux affich...

WASHINGTON--(BUSINESS WIRE)--Best Medical International (BMI), a TeamBest Global (TBG) company, celebrates its 50th anniversary this year, marking five decades of innovation, technological advancement, and a commitment to improving clinical outcomes and saving lives. After losing his father to colon cancer in 1968, Dr. Krishnan Suthanthiran founded BMI and as President, has dedicated his career to advancing cancer care and developing technologies and initiatives designed to improve the lives of...